Global Biomarker Clinical Phase Outsourcing Services Market Size To Exceed USD 46.5 Billion By 2033 l CAGR of 20.02% [Yahoo! Finance]
Labcorp Holdings Inc. (LH)
Last labcorp holdings inc. earnings: 4/29 06:53 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=84636&p=irol-irhome
Company Research
Source: Yahoo! Finance
Phase Outsourcing Services Market Size is Expected to Reach USD 46.5 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Laboratory Corporation of America Holdings, Fujirebio lnc., Charles River Laboratories, Parexel International Corporation, ICON plc, Proteome Sciences, WuXi AppTec, NorthEast BioAnalytical Laboratories LLC, Eurofins Scientific, GenScript ProBio, Celerion, and Others New York, United States , June 20, 2024 (GLOBE NEWSWIRE) -- The Global Biomarker Clinical Phase Outsourcing Services Market Size is to Grow from USD 7.5 Billion in 2023 to USD 46.5 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 20.02% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4592 Biomarker clinical phase outsourcing services refer to the use of biological indicators in drug development, supporting various stages of clinical trials, including study design, patient
Show less
Read more
Impact Snapshot
Event Time:
LH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LH alerts
High impacting Labcorp Holdings Inc. news events
Weekly update
A roundup of the hottest topics
LH
News
- Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
- Advantage Healthcare Holdings Appoints Dinak Nair as Chief Executive OfficerBusiness Wire
- Labcorp to Announce Third Quarter Financial Results on October 24, 2024PR Newswire
- Laboratory Co. of America Holdings (NYSE: LH) had its price target lowered by analysts at Evercore ISI from $250.00 to $240.00. They now have an "in-line" rating on the stock.MarketBeat
- LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion [Yahoo! Finance]Yahoo! Finance
LH
Earnings
- 8/1/24 - Beat
LH
Sec Filings
- 9/24/24 - Form 8-K
- 9/23/24 - Form 8-K
- 9/18/24 - Form 8-K
- LH's page on the SEC website